A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients

Mild to Moderate Atopic Dermatitis Clinical Trial

Official title:
A Randomized, Placebo/Active Controlled, Single/Multiple Dosing, Dose Escalation Clinical Phase 1a/b Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of IN-A002 Ointment in Healthy Adult Male Volunteers and Mild to Moderate Atopic Dermatitis Patients

Status Not yet recruiting

Clinical Trial Summary

This study aims to evaluate the safety, tolerability and pharmacokinetic properties of IN-A002 Ointment in healthy adult male volunteers and mild to moderate atopic dermatitis patients

Clinical Trial Description

Part A: Phase 1a Study - Primary objective - To evaluate the safety and tolerability after single/multiple dosing of topical IN-A002 Ointment in healthy adult male volunteers. - Secondary objective - To evaluate the pharmacokinetic (PK) profile after single/multiple dosing of topical IN-A002 Ointment in healthy adult male volunteers Part B: Phase 1b Study - Primary objective - To evaluate the safety and tolerability after multiple dosing of topical IN-A002 Ointment in patients with mild to moderate atopic dermatitis. - Secondary objectives - To evaluate the PK profile after multiple dosing of topical IN-A002 Ointment in patients with mild to moderate atopic dermatitis. - To evaluate the efficacy after multiple dosing of topical IN-A002 Ointment in patients with mild to moderate atopic dermatitis. ;

Study Design

Related Conditions & MeSH terms

Dermatitis
Dermatitis, Atopic
Eczema
Mild to Moderate Atopic Dermatitis

Clinical Trial Details

NCT number	NCT05729074
Study type	Interventional
Source	HK inno.N Corporation
Contact	Haerim Jang
Phone	+82-2-6477-0206
Email	haerim.jang@inno-n.com
Status	Not yet recruiting
Phase	Phase 1
Start date	February 13, 2023
Completion date	January 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05057351` - A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis	N/A
Active, not recruiting	`NCT03250663` - Eucrisa for Atopic Dermatitis	Phase 1
Not yet recruiting	`NCT06052995` - Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis.
Terminated	`NCT00996008` - CT 327 in the Treatment of Atopic Dermatitis	Phase 2
Completed	`NCT01568489` - Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis	Phase 2
Completed	`NCT01079897` - Efficacy and Safety of an Ectoine-containing Cream in the Treatment of Mild to Moderate Atopic Dermatitis	N/A
Completed	`NCT02079688` - Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema	Phase 2
Completed	`NCT00568412` - A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis	Phase 4